Web Research
Web Research
Figures converted from TWD at historical FX rates — see data/fx_rates.json for the rate table. Ratios, margins, multiples, and percentages are unitless and unchanged.
The Bottom Line from the Web
The internet tells a story that the static FY2023 / FY2024 filings cannot: Msscorps' shares are up roughly 480% in twelve months and 329% year-to-date while the company has just swung to a net loss in FY2025 and posted another loss in Q1 2026. The single most material non-filing finding is the Dec 17, 2025 Taipei Times disclosure that the new MSS USA lab serves Apple, Nvidia, Applied Materials and Lam Research — the named-hyperscaler proof that anchors the AI/Silicon-Photonics bull narrative driving the multiple. Everything else (a new CPO inspection equipment business launching late-2026, a $7.0M offensive patent suit against Enli Technology, a $16.5M convertible bond, and the only published broker target of $7.14 from Masterlink Securities) sits underneath that price-vs-fundamentals divergence.
What Matters Most
Last Price ($)
Market Cap ($B)
1Y Return (×)
Sole Broker Target ($)
EPS TTM ($)
EV/EBITDA (prior yr-end)
1. Stock has soared while earnings turned negative
Yahoo Finance shows 6830.TW at $26.11 on 2026-05-13, up +478.29% over 1Y and +328.74% YTD, with a 52-week range of $4.06 to $35.00. Yet trailing EPS is −$0.025 and trailing P/E is N/A (negative). Trailing P/E ended FY2024 at 65.2×, climbed to 97.8× at 3/31/2025, 201.7× at 6/30/2025, and then NA after 9/30/2025 as earnings flipped negative. Price/Sales has expanded from 3.94× at 12/31/2024 to 18.71× currently.
The Financial Times income-statement view spells it out: net income fell from a gain of $2.27M to a loss of $1.28M even as revenue rose +10.78% from $68.8M to $76.3M. Cost of goods sold widened from 73.34% to 76.30% of sales — a ~3pp gross-margin compression. Sources: Yahoo Finance, FT.com.
2. Q1 2026 was another loss — May 7, 2026 Digitimes story
Digitimes (May 7, 2026) headlined "Msscorps posts first-quarter loss as it pivots into silicon photonics inspection" and reported Q1 2026 consolidated revenue of $18.46 million (NT$579M at the historical rate cited in the article). This is the most material post-FY2025 update — it confirms the loss is not yet behind the company even as the bull narrative leans on a FY2026 margin rebound. Digitimes link
3. Named hyperscaler customers — Apple, Nvidia, Applied Materials, Lam Research
The Taipei Times (Dec 17, 2025) reports that MSS USA Corp's Silicon-Valley lab serves US customers "from Apple Inc to Nvidia, Applied Materials Inc and Lam Research Corp." This is the first independent confirmation of a named-hyperscaler customer set and is the load-bearing fact behind the re-rating thesis. The filings disclose only "Customer A" and "Customer B" at ~22% each, so identifying the actual marquee accounts changes the moat read materially.
Sources: Taipei Times 2025-12-17, en.msscorps.com.
4. New CPO inspection equipment business — second growth engine
Per the Taipei Times (Mar 26, 2026) and Digitimes (Apr 7, 2026), Msscorps plans to launch CPO (co-packaged optics) light-leakage / IR inspection equipment by end-2026, ramping production in 2027, priced $1.4M–$3.5M per unit ("MSS HG" platform). Management describes this as a second growth engine alongside the legacy MA/FA service revenue, and the company says it holds a key patent enabling the IR-camera-based defect detection in waveguides — directly tied to Nvidia's announced CPO roadmap.
Sources: Taipei Times 2026-03-26, Digitimes 2026-04-07.
5. $7.0M patent suit filed against Enli Technology — offensive IP posture
Msscorps filed (Mar 25, 2026) a $6.3M (NT$200M at the article's rate) patent-infringement complaint against Enli Technology (光焱科技) at Taiwan's Intellectual Property and Commercial Court, alleging infringement of Msscorps' light-leakage / photonic IC inspection patent. The shift from defensive litigant (the historical MA-tek trade-secrets case it defended) to offensive plaintiff is a material posture change and a tell on how seriously management treats the CPO/PIC opportunity.
Source: Taipei Times 2026-03-26; transaction listing at MarketScreener.
6. Only one analyst — Masterlink Securities at $7.14 (Buy)
Masterlink Securities initiated coverage Jan 2, 2026 with a Buy rating and a $7.14 price target. The stock now trades at $26.11 — roughly 3.7× the only published broker target. Yahoo Finance and WSJ list no 1-year target estimate and no recent broker activity. Coverage is effectively a single-broker situation, which materially weakens the "sell-side underwriting" leg of the price.
Source: MarketScreener news feed.
7. $16.5M convertible bond — dilution overhang, terms not publicly disclosed
The forensic specialist flagged a first-ever $16.5M convertible bond disclosed in FY2024 filings (+$41M non-current liabilities). Despite extensive search, the conversion price, maturity, and holder list have not surfaced in publicly available media coverage. This leaves the dilution path unsized at a moment when the stock is up 480%. A separate Marketscreener note also flagged MSS USA Corp expecting to receive $20M in funding from the parent — consistent with continued capital intensity at the US sub.
Sources: forensic-claude specialist query #5 in specialist-queries.json; Marketscreener referenced disclosure of MSS USA funding plan.
8. Governance: Chairman's son in three concurrent roles
The sherlock specialist flagged that Chun-Hao Liu (劉宗瀚), son of Chairman Chi-Lun Liu, simultaneously holds Director, Chairman's Special Assistant, and CEO of MSS USA — the very subsidiary on which the bull thesis depends. Combined with a quietly executed independent-director swap at the June 2024 AGM (Ting-Hsun Chan replaced without disclosed cause) and a reported compensation-to-NPAT ratio of ~66% in FY2024, the family-control footprint is heavier than the AR's "routine" framing suggests.
Source: specialist-queries.json (sherlock-claude queries #12, #13, #14, #29).
9. The parabolic move's catalyst stack
From the Tech specialist query (#3): the stock moved from $9.07 (Feb 25, 2025) to $34.13 (May 5, 2026) — a ~3.8× advance in roughly 14 months. Catalyst-tagged events in the public record:
- May 7, 2025 — MSS USA grand opening (Silicon Valley)
- Aug 4, 2025 — Digitimes: chairman shrugs off 20% Taiwan import tariff
- Dec 17, 2025 — Taipei Times: named Apple/Nvidia/AMAT/Lam, AI-zone utilization stepping 25% → 75%
- Jan 2, 2026 — Masterlink initiates Buy at $7.14
- Jan 9, 2026 — Digitimes: record 4Q25 / FY2025 revenue on AI demand
- Feb 2, 2026 — Year-end gathering; 12-facility footprint
- Mar 25, 2026 — $7.0M offensive patent suit vs Enli
- Mar 31, 2026 — FY2025 earnings (revenue $76.25M, loss)
- Apr 7, 2026 — "MSS HG" CPO inspection platform unveiled
- May 7, 2026 — Q1 2026 loss confirmed
10. What the web does NOT reveal
Active searches for short-seller reports, auditor resignations, restatements, SEC/FSC enforcement actions, material weaknesses, and regulatory probes returned nothing material. No earnings-call transcripts were found in English or Chinese (only press write-ups). The information vacuum itself is a signal — for a stock that has 5×'d on AI narrative, the absence of independent forensic or institutional commentary is unusual and leaves the price especially sensitive to the next print.
Recent News Timeline
What the Specialists Asked
Governance and People Signals
Sources: 2023 Annual Report, FT.com institutional view.
Notable governance signals
- Family control footprint — Chairman Chi-Lun Liu (劉宗倫) plus son Chun-Hao Liu (Director + Chairman's SA + CEO of MSS USA). Five non-independent board seats are filled by family-/director-controlled investment vehicles per the sherlock specialist read.
- Independent-director swap (June 2024 AGM) — Ting-Hsun Chan replaced without an externally disclosed cause; characterized in filings as routine term completion. No external reporting confirms or contradicts this.
- Compensation-to-NPAT ratio reportedly spiked to ~66% in FY2024 (specialist finding) — material if confirmed, especially against the FY2025 loss.
- Dividend cut — FY2025 dividend $0.035/share vs $0.158 for FY2023, an ~78% reduction. Forward yield 0.13%.
- Public-float context — WSJ reports 51.78M shares outstanding, 29.52M public float; institutional ownership thin (top holder PGIM at 1.80%).
Insider transactions
The web does not surface any aggregated 12-month insider-buying/selling tape via TWSE MOPS in English-language sources. SEC EDGAR / SecForm4 are irrelevant (TWSE issuer). The absence of an insider-selling story despite the 480% rally is itself notable but unverified.
Industry Context
Three external industry data points add to (rather than restate) the Industry primer:
Failure-analysis market structure — IMARC and Straits Research list SIMS as the largest segment of the failure-analysis market by tool spend, with semiconductor end-use the dominant vertical. Msscorps' toolkit (SIMS + TEM + EDS + FIB/PFIB + AFM + XPS + X-ray CT + OBIRCH + proprietary LT-ALD) covers the full stack; the proprietary IR-leakage / CPO inspection capability is the only piece pitched as "monopoly-like." Sources: imarcgroup.com, straitsresearch.com.
Semiconductor testing services TAM — SNS Insider projects US$21.97B by 2033 for semiconductor testing services, but this number conflates ATE production test (where ASE, Amkor, SPIL, JCET dominate) with the R&D MA/FA niche Msscorps serves. The MA/FA-specific subpool has not been cleanly disclosed in any consulted source. Sources: SNS Insider via Yahoo Finance.
CPO demand wave — Samsung's OFC 2026 silicon-photonics roadmap (PIC → OE → CPO by 2030) and Nvidia's announced adoption of CPO for next-generation switch platforms (per Taipei Times 2025-04-03 citing Msscorps commentary) are the two demand-side anchors investors are paying for. Source: TheLec 2026-03-30.
Even against the AI-cycle high-fliers, Msscorps' 1-year tape is in the same bucket as memory leaders SK Hynix and Micron. The market is treating it as a leveraged AI-narrative play, not as a semiconductor services microcap. Source: MarketScreener peer compare.